Electromed, Inc. (ELMD)
NYSEAMERICAN: ELMD · Real-Time Price · USD
20.95
+0.17 (0.82%)
Jun 6, 2025, 4:00 PM - Market closed
Electromed Revenue
Electromed had revenue of $15.68M in the quarter ending March 31, 2025, with 13.07% growth. This brings the company's revenue in the last twelve months to $61.44M, up 14.85% year-over-year. In the fiscal year ending June 30, 2024, Electromed had annual revenue of $54.72M with 13.83% growth.
Revenue (ttm)
$61.44M
Revenue Growth
+14.85%
P/S Ratio
2.91
Revenue / Employee
$353,098
Employees
174
Market Cap
175.69M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 54.72M | 6.65M | 13.83% |
Jun 30, 2023 | 48.07M | 6.41M | 15.38% |
Jun 30, 2022 | 41.66M | 5.90M | 16.51% |
Jun 30, 2021 | 35.76M | 3.29M | 10.12% |
Jun 30, 2020 | 32.47M | 1.17M | 3.74% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
ELMD News
- 11 days ago - Electromed, Inc. to Join Russell 2000® and Russell 3000® Indexes - Business Wire
- 25 days ago - Electromed, Inc. (ELMD) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 25 days ago - Electromed, Inc. Announces Fiscal 2025 Third Quarter Results - Business Wire
- 5 weeks ago - Electromed, Inc. Schedules its Third Quarter Fiscal 2025 Financial Results Conference Call for May 13, 2025 at 5:00 p.m. ET - Business Wire
- 2 months ago - Electromed, Inc. to Present at the LD Micro Invitational XV - Newsfile Corp
- 3 months ago - Electromed, Inc. Announces Share Repurchase Authorization - Business Wire
- 3 months ago - Electromed Inc. to Participate in Upcoming Investor Conferences - Business Wire
- 4 months ago - Electromed, Inc. (ELMD) Q2 2025 Earnings Call Transcript - Seeking Alpha